CCM
IDXX icon

Coldstream Capital Management’s Idexx Laboratories IDXX Stock Holding History

Coldstream Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
2,020
+161
+9% +$90.3K 0.01% 470
2026
Q1 		$1.04M Sell
1,859
-34
-2% -$21.8K 0.01% 464
2025
Q4 		$1.28M Buy
1,893
+146
+8% +$99.4K 0.02% 388
2025
Q3 		$1.12M Buy
1,747
+162
+10% +$98.3K 0.02% 429
2025
Q2 		$850K Sell
1,585
-41
-3% -$19.6K 0.01% 470
2025
Q1 		$683K Buy
1,626
+147
+10% +$63.8K 0.01% 488
2024
Q4 		$612K Sell
1,479
-100
-6% -$43.9K 0.01% 521
2024
Q3 		$787K Buy
1,579
+115
+8% +$55.9K 0.02% 447
2024
Q2 		$713K Buy
1,464
+158
+12% +$79.3K 0.02% 418
2024
Q1 		$705K Buy
1,306
+39
+3% +$21.3K 0.02% 432
2023
Q4 		$703K Buy
1,267
+55
+5% +$25.8K 0.02% 379
2023
Q3 		$530K Sell
1,212
-70
-5% -$34.9K 0.02% 403
2023
Q2 		$644K Sell
1,282
-3
-0.2% -$1.44K 0.02% 364
2023
Q1 		$643K Buy
1,285
+39
+3% +$18.7K 0.02% 361
2022
Q4 		$508K Buy
+1,246
New +$484K 0.02% 423
2022
Q2 		$413K Buy
1,178
+321
+37% +$131K 0.02% 459
2022
Q1 		$469K Buy
857
+28
+3% +$14.7K 0.02% 410
2021
Q4 		$546K Buy
+829
New +$520K 0.02% 400
2021
Q3 		– Sell
-364
Closed -$230K – 473
2021
Q2 		$230K Buy
+364
New +$201K 0.01% 469
2019
Q1 		– Sell
-1,093
Closed -$203K – 334
2018
Q4 		$203K Sell
1,093
-37
-3% -$7.59K 0.02% 293
2018
Q3 		$282K Hold
1,130
– – 0.03% 277
2018
Q2 		$247K Sell
1,130
-178
-14% -$36.7K 0.03% 275
2018
Q1 		$251K Buy
+1,308
New +$241K 0.03% 259

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Coldstream Capital Management's IDXX Position: Q2 2026 in Review

Coldstream Capital Management increased its Idexx Laboratories (IDXX) stake by 8.7% in Q2 2026, buying an estimated $90.3K and bringing the position to 2,020 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #470.

Coldstream Capital Management first reported a position in IDXX in Q1 2018 and has held it in 23 quarters since. The position peaked at $1.28M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Coldstream Capital Management held 2,020 shares of Idexx Laboratories worth $1.06M as of Q2 2026.
  • Coldstream Capital Management bought 161 Idexx Laboratories shares in Q2 2026, an estimated $90.3K.
  • Idexx Laboratories made up 0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #470 holding.
  • Coldstream Capital Management first reported a position in Idexx Laboratories in Q1 2018 and has held it in 23 quarters since.
  • Coldstream Capital Management's Idexx Laboratories position peaked at $1.28M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.